J&J COVID Vaccine Pause After Blood Clot Risk

After six people who received the Johnson & Johnson one-dose COVID-19 vaccine developed a type of rare and severe blood clot, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention on Tuesday each said they will seek a "pause" in use of the shots as they review the data. The six cases involved what's known as a cerebral venous sinus thrombosis (CVST), a rare type of clot "seen in combination with low levels of blood platelets (thrombocytopenia),"
Read more...

;